Supplemental Guarantor and Non-Guarantor Financial Information (Details 1) (USD $) In Thousands, unless otherwise specified	3 Months Ended																9 Months Ended	12 Months Ended
	Dec. 31, 2012		Sep. 30, 2012		Jun. 30, 2012		Mar. 31, 2012		Dec. 31, 2011		Sep. 30, 2011		Jun. 30, 2011		Mar. 31, 2011		Sep. 30, 2012	Dec. 31, 2012		Dec. 31, 2011		Dec. 31, 2010
Condensed Consolidating Statement of Comprehensive Income
Total net revenues	$ 425,017		$ 424,444		$ 427,691		$ 435,652		$ 449,209		$ 449,748		$ 448,712		$ 451,109			$ 1,712,804		$ 1,798,778		$ 1,414,459
Cost of services sold																		908,741		948,455		680,074
Gross profit	195,763		200,555		204,954		202,791		208,604		206,805		214,561		220,353			804,063		850,323		734,385
Selling, general and administrative expenses																		(655,766)		(730,407)		(606,864)
Dividend income																		0		8,590	[1]	0
Gain on sale of assets and businesses, net	2,600				5,400												5,447	8,014		1,061		103
Goodwill, intangibles and other long-lived asset impairment									(643,305)									(19,132)		(643,305)	[2]	0
Interest expense and other, net																		(89,947)	[3]	(88,610)	[3]	(39,030)
Equity in earnings (loss) of subsidiaries																		0		0		0
Income (loss) from continuing operations before income taxes and equity in net earnings of CareCentrix	18,510	[4]	(2,678)	[5]	23,818	[4]	7,582		5,995		(635,830)	[5]	6,750		20,737			47,232		(602,348)		88,594
Income tax (expense) benefit																		(17,251)		75,768		(34,076)
Equity in net (loss) earnings of CareCentrix																		(2,301)		68,381		1,298
Income (loss) from continuing operations	8,570	[4],[6],[7]	(523)	[5],[6]	13,909	[4],[6]	4,840	[6]	3,366	[6]	(479,734)	[5],[6]	4,523	[6]	13,005	[6]		27,680		(458,199)		55,816
Discontinued operations, net of tax	0		0		0		0		1,219		5,983		666		447			0		8,315		(3,135)
Net income (loss)	8,570	[4],[6],[7]	(523)	[5],[6]	13,909	[4],[6]	4,840	[6]	4,585	[6]	(473,751)	[5],[6]	5,189	[6]	13,452	[6]		27,680		(449,884)		52,681
Less: Net income attributable to noncontrolling interests																		(884)		(641)		(526)
Net income (loss) attributable to Gentiva shareholders																		26,796		(450,525)		52,155
Total comprehensive income (loss)																		27,680		(450,362)		53,159
Gentiva Health Services, Inc. [Member]
Condensed Consolidating Statement of Comprehensive Income
Total net revenues																		0		0		0
Cost of services sold																		0		0		0
Gross profit																		0		0		0
Selling, general and administrative expenses																		0		0		0
Dividend income																				0
Gain on sale of assets and businesses, net																		0		0		0
Goodwill, intangibles and other long-lived asset impairment																		0		0
Interest expense and other, net																		(90,054)		(88,665)		(39,097)
Equity in earnings (loss) of subsidiaries																		79,622		(380,176)		75,652
Income (loss) from continuing operations before income taxes and equity in net earnings of CareCentrix																		(10,432)		(468,841)		36,555
Income tax (expense) benefit																		37,228		18,316		15,600
Equity in net (loss) earnings of CareCentrix																		0		0		0
Income (loss) from continuing operations																		26,796		(450,525)		52,155
Discontinued operations, net of tax																		0		0		0
Net income (loss)																		26,796		(450,525)		52,155
Less: Net income attributable to noncontrolling interests																		0		0		0
Net income (loss) attributable to Gentiva shareholders																		26,796		(450,525)		52,155
Total comprehensive income (loss)																		26,796		(451,003)		52,633
Guarantor Subsidiaries [Member]
Condensed Consolidating Statement of Comprehensive Income
Total net revenues																		1,666,368		1,757,459		1,388,234
Cost of services sold																		884,903		921,826		667,389
Gross profit																		781,465		835,633		720,845
Selling, general and administrative expenses																		(638,975)		(715,343)		(596,874)
Dividend income																				8,590
Gain on sale of assets and businesses, net																		8,014		1,061		103
Goodwill, intangibles and other long-lived asset impairment																		(19,132)		(643,305)
Interest expense and other, net																		0		0		0
Equity in earnings (loss) of subsidiaries																		3,038		221		2,033
Income (loss) from continuing operations before income taxes and equity in net earnings of CareCentrix																		134,410		(513,143)		126,107
Income tax (expense) benefit																		(52,487)		56,637		(48,336)
Equity in net (loss) earnings of CareCentrix																		(2,301)		68,381		1,298
Income (loss) from continuing operations																		79,622		(388,125)		79,069
Discontinued operations, net of tax																		0		7,949		(3,417)
Net income (loss)																		79,622		(380,176)		75,652
Less: Net income attributable to noncontrolling interests																		0		0		0
Net income (loss) attributable to Gentiva shareholders																		79,622		(380,176)		75,652
Total comprehensive income (loss)																		79,622		(380,176)		75,652
Non-Guarantor Subsidiaries [Member]
Condensed Consolidating Statement of Comprehensive Income
Total net revenues																		61,656		52,404		38,463
Cost of services sold																		39,058		37,714		24,923
Gross profit																		22,598		14,690		13,540
Selling, general and administrative expenses																		(16,791)		(15,064)		(9,990)
Dividend income																				0
Gain on sale of assets and businesses, net																		0		0		0
Goodwill, intangibles and other long-lived asset impairment																		0		0
Interest expense and other, net																		107		55		67
Equity in earnings (loss) of subsidiaries																		0		0		0
Income (loss) from continuing operations before income taxes and equity in net earnings of CareCentrix																		5,914		(319)		3,617
Income tax (expense) benefit																		(1,992)		815		(1,340)
Equity in net (loss) earnings of CareCentrix																		0		0		0
Income (loss) from continuing operations																		3,922		496		2,277
Discontinued operations, net of tax																		0		366		282
Net income (loss)																		3,922		862		2,559
Less: Net income attributable to noncontrolling interests																		(884)		(641)		(526)
Net income (loss) attributable to Gentiva shareholders																		3,038		221		2,033
Total comprehensive income (loss)																		3,922		862		2,559
Eliminations [Member]
Condensed Consolidating Statement of Comprehensive Income
Total net revenues																		(15,220)		(11,085)		(12,238)
Cost of services sold																		(15,220)		(11,085)		(12,238)
Gross profit																		0		0		0
Selling, general and administrative expenses																		0		0		0
Dividend income																				0
Gain on sale of assets and businesses, net																		0		0		0
Goodwill, intangibles and other long-lived asset impairment																		0		0
Interest expense and other, net																		0		0		0
Equity in earnings (loss) of subsidiaries																		(82,660)		379,955		(77,685)
Income (loss) from continuing operations before income taxes and equity in net earnings of CareCentrix																		(82,660)		379,955		(77,685)
Income tax (expense) benefit																		0		0		0
Equity in net (loss) earnings of CareCentrix																		0		0
Income (loss) from continuing operations																		(82,660)		379,955		(77,685)
Discontinued operations, net of tax																		0		0		0
Net income (loss)																		(82,660)		379,955		(77,685)
Less: Net income attributable to noncontrolling interests																		0		0		0
Net income (loss) attributable to Gentiva shareholders																		(82,660)		379,955		(77,685)
Total comprehensive income (loss)																		$ (82,660)		$ 379,955		$ (77,685)

[1] For the year ended December 31, 2011, the Company recognized dividend income of $8.6 million as a result of the sale of a portion of the Company’s combined common and preferred ownership of CareCentrix.

[2] For the year ended December 31, 2012, the Company recorded non-cash impairment charges associated with a write-off of its trade name intangibles of $19.1 million in connection with the Company's initiative to re-brand its operations under the Gentiva name. Home Health and Hospice assets were reduced by $6.0 million and $13.1 million, respectively, as of December 31, 2012 as a result of the impairment.For the year ended December 31, 2011, the Company recorded non-cash impairment charges associated with goodwill, intangibles and other long-lived assets of $643.3 million. This charge was the result of (i) changes in the Company's business climate, (ii) uncertainties around Medicare reimbursement as the federal government worked to reduce the federal deficit, (iii) a significant decline in the price of the Company's common stock during the fiscal year, (iv) a write-down of software and (v) a change in the estimated fair value of real estate. Home Health, Hospice and corporate assets were reduced by $408.4 million, $193.7 million and $41.2 million, respectively, as of December 31, 2011, as a result of the impairment.

[3] For the year ended December 31, 2012, interest expense and other, net included charges of $0.5 million relating to the write-off of deferred debt issuance costs associated with the revolving credit facility. In addition, interest expense and other, net for the year ended December 31, 2011 included charges of $3.8 million associated with terminating the Company’s interest rate swaps in connection with the refinancing of the Company’s Term Loan A and Term Loan B under the Company’s credit agreement. See Note 10 for additional information.

[4] For the fourth quarter of 2012, income (loss) from continuing operations before income taxes and equity in net earnings of CareCentrix, includes a $2.6 million pre-tax gain related to the sale of the Phoenix area hospice operations. For the second quarter of 2012, Income (loss) from continuing operations before income taxes and equity in net earnings of CareCentrix, includes a $5.4 million pre-tax gain associated with the sale of (i) the Gentiva consulting business and (ii) the sale of eight home health branches and four hospice branches in Louisiana.

[5] For the third quarter of 2012, the Company recorded non-cash impairment charges associated with a write-off of its trade name intangibles of $19.1 million in connection with the Company's initiative to re-brand its operations under the Gentiva name. For the third quarter of 2011, the Company recorded non-cash impairment charges associated with goodwill, intangibles and other long-lived assets of $643.3 million. This charge was the result of (i) changes in the Company's business climate, (ii) uncertainties around Medicare reimbursement as the federal government worked to reduce the federal deficit, (iii) a significant decline in the price of the Company's common stock during the fiscal year, (iv) a write-down of software and (v) a change in the estimated fair value of real estate. See Notes 8 and 9.

[6] Income (loss) from continuing operations before income taxes and equity in net earnings of CareCentrix, including gain on sale for each of the 2012 and 2011 quarters includes charges relating to cost savings initiatives, integration and acquisition activities, other restructuring and legal settlements as follows (in thousands): FirstQuarter SecondQuarter ThirdQuarter FourthQuarterYear ended December 31, 2012$5,391 $25 $53 $201Year ended December 31, 2011$3,765 $21,246 $9,845 $14,282

[7] In anticipation of a settlement of claims alleged by the owner of CareCentrix and working capital adjustments as set forth in the stock purchase agreement, during the fourth quarter, the Company recorded a $6.5 million adjustment to the seller financing note receivable to reflect its revised estimated fair value of $3.4 million, which is recorded in equity in net loss of CareCentrix.